INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2026-01-30 14:25Core Viewpoint - The stock of Yingke Medical (300677) has shown a recent increase in price and trading activity, with significant fluctuations in capital flow over the past few days, indicating varying investor sentiment and market dynamics [1][2]. Group 1: Stock Performance - As of January 30, 2026, Yingke Medical closed at 41.86 yuan, up by 2.57%, with a turnover rate of 2.51% and a trading volume of 117,100 hands, resulting in a transaction amount of 481 million yuan [1]. - The capital flow data on January 30 shows a net inflow of 13.47 million yuan from institutional investors, accounting for 2.8% of the total transaction amount, while retail investors experienced a net outflow of 38.84 million yuan, representing 8.07% of the total [1][2]. Group 2: Recent Capital Flow Trends - Over the past five days, the stock has experienced significant capital flow changes, with the following highlights: - On January 29, the stock price fell by 3.41%, with a net outflow of 29.02 million yuan from institutional investors [2]. - On January 28, the stock price decreased by 3.23%, with a net outflow of 72.13 million yuan from institutional investors [2]. - On January 26, the stock price increased by 2.56%, with a net inflow of 61.63 million yuan from institutional investors [2]. Group 3: Company Financial Metrics - Yingke Medical's total market capitalization is 27.425 billion yuan, with a net asset value of 18.467 billion yuan and a net profit of 924 million yuan, ranking 7th in the medical device industry [3]. - The company reported a gross margin of 23.7% and a net profit margin of 12.82%, with a return on equity (ROE) of 5.19% [3]. - For the first three quarters of 2025, the company achieved a main business revenue of 7.425 billion yuan, a year-on-year increase of 4.6%, while the net profit attributable to shareholders rose by 34.47% to 924 million yuan [3].